Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells

Blanka Sestáková1, Lubica Ondrusová, Jiri Vachtenheim

  • 1Laboratory of Molecular Biology, University Hospital, Charles University, Prague, Czech Republic.

Insights

The p21 protein boosts microphthalmia-associated transcription factor (MITF) in melanoma, potentially explaining high p21 levels. This discovery reveals a positive feedback loop crucial for melanoma cell survival.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • p21/WAF1/Cip1 (p21) is a cyclin-dependent kinase inhibitor with dual roles in cancer, potentially acting as an antioncogene or tumor promoter.
  • Elevated p21 protein levels are observed in some melanomas, but the underlying mechanisms remain unclear.
  • Microphthalmia-associated transcription factor (MITF) is critical for melanocyte development and melanoma cell survival.

Purpose of the Study:

  • To investigate the regulatory relationship between p21 and MITF in melanoma cells.
  • To elucidate the mechanism by which high p21 levels are tolerated in melanoma.
  • To explore the potential for a positive feedback loop between p21 and MITF.

Main Methods:

  • Reporter assays to assess MITF promoter activity.
  • In vivo promoter occupancy studies.
  • Knockdown of p21 using short hairpin RNA (shRNA).
  • Correlation analysis of p21 protein and MITF mRNA levels across cell lines.

Main Results:

  • p21 directly activates the MITF promoter and binds to it in vivo.
  • p21 cooperates with CREB (cAMP response element binding protein) to enhance MITF promoter activity.
  • p21 knockdown leads to reduced MITF protein levels and promoter activity.
  • p21 protein levels positively correlate with MITF mRNA levels in most tested melanoma cell lines.

Conclusions:

  • p21 positively regulates MITF transcription in melanoma cells.
  • A reciprocal transcriptional feedback loop exists between p21 and MITF, reinforcing MITF expression.
  • This feedback loop may explain the tolerance of high p21 levels in certain melanomas.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.